Victory Capital Management Inc Summit Therapeutics Inc. Transaction History

Victory Capital Management Inc

  • $98.4 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 06, 2023
BUY
$1.54 - $2.42 $560 - $880
364 Added 3.06%
12,267 $22,000
Q2 2023

Jul 27, 2023
SELL
$1.32 - $2.81 $365 - $778
-277 Reduced 2.27%
11,903 $29,000
Q1 2023

May 02, 2023
BUY
$1.38 - $5.41 $16,808 - $65,893
12,180 New
12,180 $21,000

Others Institutions Holding SMMT

# of Institutions
107
Shares Held
41.3M
Call Options Held
103K
Put Options Held
29.9K
View Full List

About Summit Therapeutics Inc.

SMMT Quotes by TradingView
  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $1.52B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email